-
Something wrong with this record ?
Residual Cdk1/2 activity after DNA damage promotes senescence
E. Müllers, H. Silva Cascales, K. Burdova, L. Macurek, A. Lindqvist,
Language English Country Great Britain
Document type Journal Article
NLK
Directory of Open Access Journals
from 2014
Free Medical Journals
from 2002 to 2 years ago
PubMed Central
from 2008
ProQuest Central
from 2014-02-01 to 2017-12-31
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2014-01-01
Medline Complete (EBSCOhost)
from 2003-02-01
Wiley-Blackwell Open Access Titles
from 2002
ROAD: Directory of Open Access Scholarly Resources
from 2002
PubMed
28345297
DOI
10.1111/acel.12588
Knihovny.cz E-resources
- MeSH
- Single-Cell Analysis MeSH
- Cell Line MeSH
- Quinolines pharmacology MeSH
- Cyclin B1 genetics metabolism MeSH
- Cyclin-Dependent Kinase 2 antagonists & inhibitors genetics metabolism MeSH
- Epithelial Cells cytology drug effects enzymology MeSH
- Etoposide pharmacology MeSH
- Cyclin-Dependent Kinase Inhibitor p21 genetics metabolism MeSH
- Cadherins genetics metabolism MeSH
- G2 Phase Cell Cycle Checkpoints drug effects MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Osteoblasts cytology drug effects enzymology MeSH
- DNA Damage MeSH
- CDC2 Protein Kinase antagonists & inhibitors genetics metabolism MeSH
- Pteridines pharmacology MeSH
- Purines pharmacology MeSH
- Gene Expression Regulation MeSH
- Retinal Pigment Epithelium cytology drug effects enzymology MeSH
- Signal Transduction MeSH
- Cellular Senescence drug effects MeSH
- Thiazoles pharmacology MeSH
- Cell Size MeSH
- Cell Survival drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
In response to DNA damage, a cell can be forced to permanently exit the cell cycle and become senescent. Senescence provides an early barrier against tumor development by preventing proliferation of cells with damaged DNA. By studying single cells, we show that Cdk activity persists after DNA damage until terminal cell cycle exit. This low level of Cdk activity not only allows cell cycle progression, but also promotes cell cycle exit at a decision point in G2 phase. We find that residual Cdk1/2 activity is required for efficient p21 production, allowing for nuclear sequestration of Cyclin B1, subsequent APC/CCdh1 -dependent degradation of mitotic inducers and induction of senescence. We suggest that the same activity that triggers mitosis in an unperturbed cell cycle enforces senescence in the presence of DNA damage, ensuring a robust response when most needed.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016701
- 003
- CZ-PrNML
- 005
- 20180517110503.0
- 007
- ta
- 008
- 180515s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/acel.12588 $2 doi
- 035 __
- $a (PubMed)28345297
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Müllers, Erik $u Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
- 245 10
- $a Residual Cdk1/2 activity after DNA damage promotes senescence / $c E. Müllers, H. Silva Cascales, K. Burdova, L. Macurek, A. Lindqvist,
- 520 9_
- $a In response to DNA damage, a cell can be forced to permanently exit the cell cycle and become senescent. Senescence provides an early barrier against tumor development by preventing proliferation of cells with damaged DNA. By studying single cells, we show that Cdk activity persists after DNA damage until terminal cell cycle exit. This low level of Cdk activity not only allows cell cycle progression, but also promotes cell cycle exit at a decision point in G2 phase. We find that residual Cdk1/2 activity is required for efficient p21 production, allowing for nuclear sequestration of Cyclin B1, subsequent APC/CCdh1 -dependent degradation of mitotic inducers and induction of senescence. We suggest that the same activity that triggers mitosis in an unperturbed cell cycle enforces senescence in the presence of DNA damage, ensuring a robust response when most needed.
- 650 _2
- $a proteinkinasa CDC2 $x antagonisté a inhibitory $x genetika $x metabolismus $7 D016203
- 650 _2
- $a kadheriny $x genetika $x metabolismus $7 D015820
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a velikost buňky $7 D048429
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a stárnutí buněk $x účinky léků $7 D016922
- 650 _2
- $a cyklin B1 $x genetika $x metabolismus $7 D056744
- 650 _2
- $a cyklin-dependentní kinasa 2 $x antagonisté a inhibitory $x genetika $x metabolismus $7 D051357
- 650 _2
- $a inhibitor p21 cyklin-dependentní kinasy $x genetika $x metabolismus $7 D050759
- 650 _2
- $a poškození DNA $7 D004249
- 650 _2
- $a epitelové buňky $x cytologie $x účinky léků $x enzymologie $7 D004847
- 650 _2
- $a etoposid $x farmakologie $7 D005047
- 650 _2
- $a kontrolní body fáze G2 buněčného cyklu $x účinky léků $7 D059565
- 650 _2
- $a regulace genové exprese $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a osteoblasty $x cytologie $x účinky léků $x enzymologie $7 D010006
- 650 _2
- $a pteridiny $x farmakologie $7 D011621
- 650 _2
- $a puriny $x farmakologie $7 D011687
- 650 _2
- $a chinoliny $x farmakologie $7 D011804
- 650 _2
- $a retinální pigmentový epitel $x cytologie $x účinky léků $x enzymologie $7 D055213
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a analýza jednotlivých buněk $7 D059010
- 650 _2
- $a thiazoly $x farmakologie $7 D013844
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Silva Cascales, Helena $u Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Burdova, Kamila $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Macurek, Libor $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Lindqvist, Arne $u Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
- 773 0_
- $w MED00007638 $t Aging cell $x 1474-9726 $g Roč. 16, č. 3 (2017), s. 575-584
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28345297 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180517110639 $b ABA008
- 999 __
- $a ok $b bmc $g 1300325 $s 1013541
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 16 $c 3 $d 575-584 $e 20170326 $i 1474-9726 $m Aging cell $n Aging cell $x MED00007638
- LZP __
- $a Pubmed-20180515